If Medicare decides to cover the controversial Alzheimer’s drug, the price drop could benefit program costs.
Join The Ecosystem
If Medicare decides to cover the controversial Alzheimer’s drug, the price drop could benefit program costs.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.